Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$269.37 - $365.04 $3,232 - $4,380
12 New
12 $3,000
Q2 2023

Jul 26, 2023

SELL
$359.49 - $486.4 $38,105 - $51,558
-106 Reduced 82.17%
23 $8,000
Q1 2023

Apr 19, 2023

SELL
$418.69 - $503.0 $2,512 - $3,018
-6 Reduced 4.44%
129 $61,000
Q4 2022

Jan 26, 2023

SELL
$351.71 - $456.01 $138,925 - $180,123
-395 Reduced 74.53%
135 $0
Q3 2022

Nov 17, 2022

SELL
$412.59 - $563.26 $7,839 - $10,701
-19 Reduced 3.46%
530 $221,000
Q2 2022

Aug 09, 2022

BUY
$463.67 - $597.16 $5,100 - $6,568
11 Added 2.04%
549 $272,000
Q1 2022

May 03, 2022

SELL
$524.57 - $735.42 $3,671 - $5,147
-7 Reduced 1.28%
538 $303,000
Q4 2021

Feb 08, 2022

SELL
$708.84 - $794.68 $81,516 - $91,388
-115 Reduced 17.42%
545 $411,000
Q3 2021

Oct 19, 2021

SELL
$657.71 - $825.77 $23,019 - $28,901
-35 Reduced 5.04%
660 $492,000
Q2 2021

Jul 23, 2021

SELL
$576.64 - $649.04 $6,343 - $7,139
-11 Reduced 1.56%
695 $447,000
Q1 2021

Apr 23, 2021

SELL
$547.01 - $662.35 $49,230 - $59,611
-90 Reduced 11.31%
706 $403,000
Q4 2020

Jan 29, 2021

SELL
$510.68 - $643.45 $20,937 - $26,381
-41 Reduced 4.9%
796 $464,000
Q3 2020

Oct 22, 2020

SELL
$454.43 - $535.6 $17,722 - $20,888
-39 Reduced 4.45%
837 $431,000
Q2 2020

Jul 14, 2020

SELL
$334.87 - $493.06 $395,816 - $582,796
-1,182 Reduced 57.43%
876 $395,000
Q1 2020

Apr 17, 2020

SELL
$320.01 - $409.07 $1,280 - $1,636
-4 Reduced 0.19%
2,058 $721,000
Q3 2019

Oct 28, 2019

BUY
$304.55 - $345.24 $621,891 - $704,980
2,042 Added 10210.0%
2,062 $686,000
Q2 2019

Jul 12, 2019

BUY
$286.93 - $312.59 $1,147 - $1,250
4 Added 25.0%
20 $0
Q1 2019

Apr 26, 2019

BUY
$224.3 - $317.41 $3,588 - $5,078
16 New
16 $0

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.